Marshall Wace’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Hold |
47,480
| – | – | ﹤0.01% | 2342 |
|
|
2025
Q1 | $106K | Buy |
+47,480
| New | +$106K | ﹤0.01% | 2364 |
|
|
2023
Q1 | – | Sell |
-97,600
| Closed | -$989K | – | 2070 |
|
|
2022
Q4 | $989K | Sell |
97,600
-256,797
| -72% | -$2.6M | ﹤0.01% | 1605 |
|
|
2022
Q3 | $3.51M | Sell |
354,397
-159,313
| -31% | -$1.58M | 0.01% | 1333 |
|
|
2022
Q2 | $5.47M | Buy |
+513,710
| New | +$5.47M | 0.01% | 1141 |
|
|
2021
Q4 | – | Sell |
-338,120
| Closed | -$6.78M | – | 3096 |
|
|
2021
Q3 | $6.78M | Buy |
338,120
+64,841
| +24% | +$1.3M | 0.03% | 695 |
|
|
2021
Q2 | $6.01M | Buy |
273,279
+222,638
| +440% | +$4.9M | 0.03% | 662 |
|
|
2021
Q1 | $1.72M | Sell |
50,641
-461,769
| -90% | -$15.7M | 0.01% | 1198 |
|
|
2020
Q4 | $20.6M | Buy |
+512,410
| New | +$20.6M | 0.11% | 162 |
|